Recalls published in July 2026
Everything the FDA, USDA FSIS, CPSC and NHTSA announced in July 2026, newest first.
-
Class II · 3 months ago
Precision Dose Inc. Glycopyrrolate Oral Solution, 1 mg/5 mL, delivers 5 mL recall: Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 125 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Glycopyrrolate Injection, USP, 1 mg per 5 mL recall: Presence of Particulate Matter: Hair was found in product
Presence of Particulate Matter: Hair was found in product
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Xylocaine , 1%, 500 mg per 50 mL , 25 Multiple-Dose Vials recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Rohto-Mentholatum Co., Ltd. Rohto Cooling Eye Drops Optic Glow , Sterile, 0.4 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 112 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 25 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 3 months ago
Ascend Laboratories, LLC Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg recall: Failed Dissolution Specifications; Olmesartan Medoxomil content below
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
-
Class III · 3 months ago
Asclemed USA Inc. Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% vial recall: Labeling: Not Elsewhere Classified: The label wrap covers the barcode
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
-
Class II · 3 months ago
Bionpharma Inc. Divalproex Sodium Delayed-Release Tablets, USP, 500 mg recall: Presence of Foreign Tablets/Capsules
Presence of Foreign Tablets/Capsules
-
Class II · 3 months ago
Rohto-Mentholatum Co., Ltd. Rohto Cooling Eye Drops Max Strength , Sterile, Twin Pack recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 50 mcg recall: Subpotent Drug
Subpotent Drug
-
Class III · 3 months ago
Ascend Laboratories, LLC Dabigatran etexilate Capsules, 150 mg, 20-count carton recall: Failed Impurities/Degradation Specifications: OOS result was observed during
Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II…
-
Class II · 3 months ago
Rohto-Mentholatum Co., Ltd. Rohto Cooling Eye Drops Dry Aid , Sterile, 0.34 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Xylocaine , 1%, 200 mg per 20 mL , 25 Multiple-Dose Vials recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Rohto-Mentholatum Co., Ltd. Rohto Cooling Eye Drops Digi Eye , Sterile, 0.4 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 25 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 125 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 75 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Naropin , 0.5%, 100 mg per 20 mL , Twenty-five recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 88 mcg recall: Subpotent Drug
Subpotent Drug
-
Class III · 3 months ago
Supernus Pharmaceuticals, Inc. Trokendi XR, topiramate extended-release capsules recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 150 mcg recall: Subpotent Drug
Subpotent Drug